Metjet PG 1mg/500mg/15mg Tablet SR
Marketer
Medisoft Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metjet PG 1mg/500mg/15mg Tablet SR
Diabetic patients with type 2 mellitus can benefit from Glycemia Control SR, a triple-combination tablet (1mg/500mg/15mg) designed to manage blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances insulin effectiveness, thus reducing blood sugar. Always follow your physician's prescribed dosage and regimen. Ingesting it with food minimizes stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. An overdose can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, or those pregnant or breastfeeding, must consult their doctor before starting treatment. Kidney function tests are typically performed prior to initiating this therapy. Limiting alcohol consumption is advisable to reduce the risk of adverse reactions.
Uses of Metjet PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metjet PG 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metjet PG 1mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of Metjet PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metjet PG 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metjet PG 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Metjet PG 1mg/500mg/15mg Tablet SR works:
Metjet PG 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Metjet PG 1mg/500mg/15mg SR Tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Metjet PG 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Metjet PG 1mg/500mg/15mg tablet's use while breastfeeding is likely inadvisable. Scant clinical evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metjet PG 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. This medication is contraindicated in those with severe kidney disease. Routine kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Metjet PG 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Metjet PG 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Metjet PG 1mg/500mg/15mg Tablet SR :
Should you forget a Metjet PG 1mg/500mg/15mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metjet PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently